Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость - читать онлайн книгу. Автор: Ли Ноу cтр.№ 73

Shah N. L., Gordon F. D. N-acetylcysteine for acetaminophen overdose: when enough is enough. Hepatology. 2007 Sep; 46(3):939–41.

Sirvent P., et al. Simvastatin induces impairment in skeletal muscle while heart is protected. Biochem Biophys Res Commun. 2005 Dec 23; 338(3):1426–34. doi:10.1016/j.bbrc.2005.10.108.

Sirvent P., et al. Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle. Biochem Biophys Res Commun. 2005 Apr 15;329(3):1067–75. doi:10.1016/j.bbrc.2005.02.070.

Souza M. E., et al. Effect of fluoxetine on rat liver mitochondria. Biochem Pharmacol. 1994 Aug 3; 48(3):535–41. doi:10.1016/0006-2952(94)90283-6.

Vaughan R. A., et al. Ubiquinol rescues simvastatin-suppression of mitochondrial content, function and metabolism: implications for statin-induced rhabdomyolysis. Eur J Pharmacol. 2013 Jul 5; 711(1–3):1–9. Epub 2013 Apr 24. doi:10.1016/j.ejphar.2013.04.009.

Velho J. A., et al. Statins induce calcium-dependent mitochondrial permeability transition. Toxicology. 2006 Feb; 219(1–3):124–32.

Wang M. Y., Sadun A. A. Drug-related mitochondrial optic neuropathies. J Neuroophthalmol. 2013 Jun;33(2):172–8. doi:10.1097/ WNO.0b013e3182901969.

Westwood F. R., et al. Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity. Toxicol Pathol. 2005; 33(2):246–57. doi:10.1080/01926230590908213.

Xia Z., et al. Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine, clomipramine, and citalopram and the effects on these changes by Bcl-2 and BclX(L). Biochem Pharmacol. 1999 May 15; 57(10):1199–208.

Xue S. Y., et al. Nucleoside reverse transcriptase inhibitors induce a mitophagy-associated endothelial cytotoxicity that is reversed by coenzyme Q10 cotreatment. Toxicol Sci. 2013 Aug;134(2):323–34. Epub 2013 May 2. doi:10.1093/toxsci/kft105.

Yousif W. Microscopic studies on the effect of alprazolam (Xanax) on the liver of mice. Pak J Biol Sci. 2002; 5(11):1220–5. doi:10.3923/ pjbs.2002.1220.1225.

Zhao C., Shichi H. Prevention of acetaminophen-induced cataract by a combination of diallyl disulfide and N-acetylcysteine. J Ocul Pharmacol Ther. 1998 Aug; 14(4):345–55. doi:10.1089 /jop.1998.14.345.

Митохондриальный синдром

Bainbridge, L. Understanding and coping with mitochondrial disease. Hamilton, ON: Hamilton Health Sciences; 2010.

Bertini E., D’Amico A. Mitochondrial encephalomyopathies and related syndromes [review]. Endocr Dev. 2009; 14:38–52.

Debray F. G., Lambert M., Mitchell G. A. Disorders of mitochondrial function. Curr Opin Pediatr. 2008 Aug; 20(4):471–82. doi:10.1097/ MOP.0b013e328306ebb6.

DiMauro S., Schon E. A. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003 Jun; 348(26):2656–68. doi:10.1056/NEJMra022567.

DiMauro S., et al. Diseases of oxidative phosphorylation due to mtDNA mutations. Semin Neurol. 2001 Sep; 21(3):251–60. doi:10.1055/s-2001-17942. Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol. 2008 Oct; 39(4):223–35. doi:10.1016/j.pediatrneurol.2008.07.013.

Folkers K., Simonsen R. Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies. Biochim Biophys Acta. 1995 May 24; 1271(1):281–6.

Goldstein A. C., Bhatia P., Vento J. M. Mitochondrial disease in childhood: nuclear encoded. Neuro-therapeutics. 2013 Apr; 10(2):212–26. Epub Mar 21 2013. doi:10.1007/s13311-013-0185-6.

Kisler J. E., Whittaker R. G., McFarland R. Mitochondrial diseases in childhood: a clinical approach to investigation and management. Dev Med Child Neurol. 2010 May; 52(5):422–33. doi:10.1111/j.1469–8749.2009.03605.x.

Koenig M. K. Presentation and diagnosis of mitochondrial disorders in children. Pediatr Neurol. 2008 May; 38(5):305–13. doi:10.1016/j.pediatr-neurol.2007.12.001.

Li H., et al. Comparative bioenergetic study of neuronal and muscle mitochondria during aging. Free Radic Biol Med. 2013 Oct; 63:30–40. Epub Apr 30 2013. doi:10.1016/j.freeradbiomed.2013.04.030.

Lodi R., et al. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich’s ataxia. Ann Neurol. 2001 May 1; 49(5):590–6. doi:10.1002/ana.1001.

McFarland R., Taylor R. W, Turnbull D. M. A neurological perspective on mitochondrial disease. Lancet Neurol. 2010 Aug; 9(8):829–840. doi:10.1016/S1474-4422(10)70116-2.

Siciliano G., et al. Functional diagnostics in mitochondrial diseases. Biosci Rep. 2007 Jun; 27(1–3):53–67. doi:10.1007/s10540-007-9037-0.

Sproule D. M., Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann NY Acad Sci. 2008 Oct; 1142:133–58. doi:10.1196/annals.1444.011.

Tarnopolsky M. A, Raha S. Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med Sci Sports Exerc. 2005 Dec; 37(12):2086–93.

Taylor R. W., Turnbull D. M. Mitochondrial DNA mutations in human disease. Nat Rev Genet. 2005 May; 6(5):389–402. doi:10.1038/nrg1606.

Thorburn D. R. Mitochondrial disorders: prevalence, myths and advances. J Inherit Metab Dis. 2004; 27(3):349–62. doi:10.1023/ B: BOLI.0000031098.41409.55.

Tuppen H. A., et al. Mitochondrial DNA mutations and human disease. Biochim Biophys Acta. 2010 Feb; 1797(2):113–28. doi:10.1016/j.bba-bio.2009.09.005.

Uitto J., Bernstein E. F. Molecular mechanisms of cutaneous aging: connective tissue alterations in the dermis. J Investig Dermatol Symp Proc. 1998 Aug; 3(1):41–4.

Waller J. M., Maibach H. I. Age and skin structure and function, a quantitative approach (II): protein, glycosaminoglycan, water, and lipid content and structure. Skin Res Technol. 2006 Aug; 12(3):145–54. doi:10.1111/j.0909752X.2006.00146.x.

Возрастная тугоухость

Bai U., et al. Mitochondrial DNA deletions associated with aging and possibly presbycusis: a human archival temporal bone study. Am J Otol. 1997 Jul;18(4):449–53.

Chen F. Q., et al. Mitochondrial peroxiredoxin 3 regulates sensory cell survival in the cochlea. PLoS One. 2013 Apr 23; 8(4):e61999. doi:10.1371/ journal.pone.0061999.

Dahl H. H., et al. Etiology and audiological outcomes at 3 years for 364 children in Australia. PLoS One. 2013;8(3):e59624. Epub 2013 Mar 28. doi:10.1371/journal.pone.0059624.

Ding Y., et al. The role of mitochondrial DNA mutations in hearing loss. Biochem Genet. 2013 Aug;51(7–8):588–602. Epub Apr 21 2013. doi:10.1007/s10528-013-9589-6.